Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Buckey's Bottom Bounce Short Term Picks (CDN ONLY) -- Ignore unavailable to you. Want to Upgrade?

To: James Lee Baldwin who wrote (3894)	10/23/2001 12:04:30 PM
From: Rocket Red	Read Replies (1) \| Respond to of 5887

Source Announces Potential To Irradiate Mail for Anthrax Rad Source Announces Potential To Irradiate Mail for Anthrax BOCA RATON, Fla., Oct 22, 2001 (BUSINESS WIRE) -- We have received many inquiries from our stockholders and potential customers as to our ability to inactivate anthrax in mail. Our design model of a low energy x-ray source shielded in a small cabinet is capable of effectively irradiating anthrax sent through the mail. Rad Source (OTCBB:IRAD) in conjunction with developers of a high output x-ray source, have concluded that an x-ray irradiator utilizing the combined technologies of both groups, has the ability to inactivate anthrax spores in mail. Based on final validation and a formalization of agreements, a small irradiator the size of a refrigerator using only x-ray (no radioactivity) would be available in January of 2002. The technology is also scalable to continuous use without increased shielding. This accelerated development of the high output technology will give us the ability to enter food irradiation and medical instrument sterilization markets much sooner than expected. Randol Kirk President and CEO of Rad Source Technologies Inc. stated, "In my opinion every mail room in the country would potentially have a need for our irradiating technology. The design and pricing of this equipment will make it easily available to every business, institution or agency in any country that may require protection for their employees and assets from bio-terrorist exposure." About Rad Source Technologies, Inc. The Company is in the business of developing and selling x-ray technology products for medical, scientific and industrial use. Its primary products substitute friendlier, non-radioactive radiation for highly regulated radioactive-isotope based equipment. The Company developed and holds a patent on the RS 3000 Blood Irradiator in the U.S. The Company's research and product development efforts include non-radioactive source radiation for various industrial applications and food irradiation. Except for the historical information contained herein, the matters discussed in this news release may contain forward-looking statements made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements involve risks and uncertainties. Rad Source Technologies, Inc.'s actual results may differ materially from the results discussed in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are the Company's inability to commercialize its technology, ability to continue and manage its growth, liquidity and other capital resources issues, competition and the other factors discussed in detail in the Company's filings with the Securities and Exchange Commission. CONTACT: Rad Source Technologies, Inc., Boca Raton Will Hartman, 561/482-9354 whartman@radsource.com URL: businesswire.com Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. Copyright (C) 2001 Business Wire. All rights reserved. -0-